Oxidative stress and inflammatory response biomarkers in dogs with mammary carcinoma
Tài liệu tham khảo
Henderson, 2000, Hormonal carcinogenesis, Carcinogenesis, 21, 427, 10.1093/carcin/21.3.427
Ingvarson, 2001, Breast cancer: introduction, Cancer Biol., 11, 323, 10.1006/scbi.2001.0381
Bostock, 1986, Canine and feline mammary neoplasms, Br. Vet. J., 142, 506, 10.1016/0007-1935(86)90107-7
Peleteiro, 1994, Tumores mamários na cadela e na gata, Rev. Portug. Ciênc. Vet., 89, 10
Misdorp, 2002, Tumors of the mammary gland, 575
Fonseca, 2000, Neoplasias mamárias em cadelas: influência hormonal e efeitos da ovário-histerctomia como terapia adjuvante, Cienc. Rural, 30, 731, 10.1590/S0103-84782000000400030
Zuccari, 2001, Fisiopatologia da neoplasia mamária em cadelas – revisão, Clin. Vet., 32, 50
Silva, 2004, Carcinogênese Hormonal e neoplasias hormônio-dependentes, Ciênc. Rural, 34, 625, 10.1590/S0103-84782004000200048
Nowak, 2007, Involvement of CD8+cells in protective mechanisms in canine mammary adenocarcinomas (short communication), Bull. Vet. Inst. Pul., 51, 445
Whitford, 1990, Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer, Br. J. Cancer, 62, 971, 10.1038/bjc.1990.419
Altomaa, 1992, Lymphocytes infiltrates as a prognostic variable in female breast cancer, Eur. J. Cancer, 28, 59, 10.1016/0959-8049(92)90134-N
Camp, 1996, In situ cytokine production by breast cancer tumor-infiltrating lymphocytes, Ann. Surg. Oncol., 3, 176, 10.1007/BF02305798
Sica, 2008, Cancer related inflammation: the macrophage connection, Cancer Lett., 264, 204, 10.1016/j.canlet.2008.03.028
Ben-baruch, 2003, Host microenvironment in breast cancer development: Inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions, Breast Cancer Res., 31, 31
Mantovani, 2007, Inflammation and cancer: the macrophage connection, Medicina, 67, 32
Lin, 2004, Minireview role of infiltrated leucocytes in tumour growth and spread, Br. J. Cancer, 90, 2053, 10.1038/sj.bjc.6601705
Coussens, 2001, Inflammatory cells and cancer: think different!, J. Exp. Med., 193, 23, 10.1084/jem.193.6.F23
Aspord, 2007, 1037
Yoo, 2009, Cytokine expression and cancer detection, Med. Sci. Monit., 15, 49
Khanduja, 2006, Nimesulide inhibits lipopolysaccharide-induced production of superoxide anions and nitric oxide and iNOS expression in alveolar macrophages, Life Sci., 78, 1662, 10.1016/j.lfs.2005.07.033
Lima, 2001, Peroxidação lipídica: mecanismos e avaliações em amostras biológicas, Rev. Bras. Ciênc. Farmacêut., 37
Briganti, 2003, Antioxidant activity, lipid peroxidation and skin diseases, Eur. Acad. Dermatol., 17, 663, 10.1046/j.1468-3083.2003.00751.x
Ralevic, 2003, Involvement of purinergic signalling in cardiovascular diseases, Drug News Perspect., 16, 40, 10.1358/dnp.2003.16.3.876886
Borovikova, 2000, Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin, Nature, 405, 458, 10.1038/35013070
Das, 2007, Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation, Med. Sci. Monit., 13, 214
Balis, 1985, Adenosine deaminase na malignant cells, Anna. N.Y. Acad. Sci., 451, 142, 10.1111/j.1749-6632.1985.tb27105.x
Nieto-Cerón, 2010, Analysis of cholinesterases in human prostate and sperm implication in cancer and fertility, Chem. Biol. Interact., 187, 432, 10.1016/j.cbi.2010.03.038
Soreq, 2001, Acetylcholinesterase new roles for an old actor, Nat. Rev. Neurosci., 2, 294, 10.1038/35067589
Ruiz-Espero, 2002, Cholinesterase activity and acetylcholinesterase glycosylation are altered in human breast cancer, Breast Cancer Res. Treat., 72, 11, 10.1023/A:1014904701723
Tatsch, 2011, A simple and inexpensive automated technique for measurement of serum nitrite/nitrate, Clin. Biochem., 44, 348, 10.1016/j.clinbiochem.2010.12.011
Hanasand, 2012, Improved detection of advanced oxidation protein products in plasma, Clin. Chim. Acta, 413, 901, 10.1016/j.cca.2012.01.038
Benzie, 1996, The ferric reducing ability of plasma (FRAP) as a measure of “Antioxidant Power”: The FRAP Assay, Anal. Biochem., 239, 70, 10.1006/abio.1996.0292
Giusti, 1974, Adenosine deaminase, 1092
Ellman, 1961, A new and rapid colorimetric determination of acetylcholinesterase activity, Biochem. Pharmacol., 7, 88, 10.1016/0006-2952(61)90145-9
Lin, 2007, A cytokine-mediated link between innate immunity, inflammation, and cancer, J. Clin. Invest., 117, 1175, 10.1172/JCI31537
Nicolini, 2006, Cytokines in breast cancer, Cytok. Growth Fact. Rev., 17, 325, 10.1016/j.cytogfr.2006.07.002
Goldberg, 2010, Proinflammatory cytokines in breast cancer: mechanisms of action and potential targets for therapeutics, Curr. Drug Targets, 11, 1133, 10.2174/138945010792006799
Kim, 2010, Lymphocyte infiltration, expression of interleukin (IL)-1, IL-6 and expression of mutated breast cancer susceptibility gene-1 correlate with malignancy of canine mammary tumours, J. Comp. Path., 142, 177, 10.1016/j.jcpa.2009.10.023
Miles, 1994, Expression of tumour necrosis factor (TNF alpha) and its receptors in benign and malignant breast tissue, Int. J. Cancer, 56, 777, 10.1002/ijc.2910560603
Sheen-Chen, 1997, Serum concentration of tumor necrosis factor in patients with breast cancer, Breast Cancer Res. Treat., 43, 211, 10.1023/A:1005736712307
Alshaker, 2011, IFN-γ, IL-17 and TGF-b involvement in shaping the tumor microenvironment: The significance of modulating such cytokines in treating malignant solid tumors, Cancer Cell Int., 11, 33, 10.1186/1475-2867-11-33
Dunn, 2006, Interferons, immunity and cancer immunoediting, Nat. Rev. Immunol., 836, 10.1038/nri1961
Shankaran, 2001, IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity, Nature, 410, 1107, 10.1038/35074122
Beatty, 2001, IFN-γ-dependent inhibition of tumor angiogenesis by tumor-infiltrating CD4+T cells requires tumor responsiveness to IFN- γ, J. Immunol., 166, 2276, 10.4049/jimmunol.166.4.2276
Dunn, 2005, Interferon-γ and cancer immunoediting, Immunol. Res., 32, 231, 10.1385/IR:32:1-3:231
Yu, 1997, IL-12-induced tumor regression correlates with in situ activity of IFN-gamma produced by tumor-infiltrating cells and its secondary induction of anti-tumor pathways, J. Leukoc. Biol., 62, 450, 10.1002/jlb.62.4.450
Kaplan, 1998, Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice, Proc. Natl. Acad. Sci. U.S.A., 95, 7556, 10.1073/pnas.95.13.7556
Piwowar, 2014, Biochemical and clinical aspects of advanced oxidation protein products in kidney diseases and metabolic disturbances, Postepy Hig. Med. Dosw, 68, 179, 10.5604/17322693.1088754
Sbarouni, 2011, Ischemia modified albumin changes: review and clinical implications, Clin. Chem. Lab. Med., 49, 177, 10.1515/CCLM.2011.037
Knowles, 1994, Nitric oxide synthases in mammals, Biochemistry, 298, 249, 10.1042/bj2980249
Ohshima, 1994, Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis, Mutation, 305, 253, 10.1016/0027-5107(94)90245-3
Lala, 1998, Significance of nitric oxide in carcinogenesis, tumor progression and cancer therapy, Cancer Metast. Rev., 17, 1, 10.1023/A:1005963400984
Tschugguel, 1999, Expression of inducible nitric oxide synthase in human breast cancer depends on tumor grade, Breast Cancer, 56, 145
Thomsen, 1994, Nitric oxide synthase activity in human gynecological cancer, Cancer Res., 54, 1352
Iwao, 2006, The structural and pharmacokinetic properties of oxidized human serum albumin and advanced oxidation protein products (AOPP), Drug Metab. Pharmacokinet., 21, 140, 10.2133/dmpk.21.140
Atabek, 2006, Protein oxidation in obesity and insulin resistance, Eur. J. Pediatr., 165, 753, 10.1007/s00431-006-0165-5
Piwowar, 2009, Markers of oxidative protein damage in plasma and urine of type 2 diabetic patients, Br. J. Biomed. Sci., 66, 194, 10.1080/09674845.2009.11730273
Sener, 2007, Lipid peroxidation and total antioxidant status in patients with breast cancer, Cell Biochem. Funct., 25, 377, 10.1002/cbf.1308
Rao, 2007, Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease, Med. Hypoth., 69, 1272, 10.1016/j.mehy.2007.03.032
Da Silva, 2013, Relationship between butyrylcholinesterase activity and liver injury in mice acute infected with Toxoplasma gondii, Pathol. Res. Pract., 209, 95, 10.1016/j.prp.2012.10.007
Lal, 1987, Serum enzymes in head and neck cancer III, J. Laryngol. Otol., 101, 1062, 10.1017/S0022215100103226
Aghaei, 2005, Adenosine deaminase activity in the serum and malignant tumors of breast cancer: the assessment of isoenzyme ADA1 and ADA2 activities, Clin. Biochem., 38, 887, 10.1016/j.clinbiochem.2005.05.015